Biomerica INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
BIOMERICA Inc. Director Eric Chin was granted 22,500 shares of common stock under the 2024 Stock Incentive Plan, vesting in December 2026.
NASDAQ
Biomerica's Chief Financial Officer, Gary Lu, received an award of 40,000 restricted common shares under the company's 2024 Stock Incentive Plan.
NASDAQ
Biomerica Inc.'s CEO, Zackary S. Irani, was awarded 52,500 shares of restricted common stock under the 2024 Stock Incentive Plan, vesting over four years.
NASDAQ
Biomerica Inc.'s Executive Vice-Chairman, Allen Barbieri, received an award of 30,000 restricted common shares under the 2024 Stock Incentive Plan.
NASDAQ
Biomerica Inc. Director David Moatazedi received an award of 20,000 restricted common shares, vesting in December 2026.
NASDAQ
Biomerica Inc. Director Gary M. Huff received an award of 20,000 restricted common shares under the company's 2024 Stock Incentive Plan, vesting in December 2026.
NASDAQ
Director Jane Emerson acquired 85,000 shares of Biomerica Inc. through the vesting of restricted stock units, while also disposing of 156,000 shares.
NASDAQ
Biomerica's CEO, Zackary S. Irani, acquired 250,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
Allen Barbieri, Executive Vice Chairman of Biomerica, acquired 110,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
Biomerica director David Moatazedi acquired 85,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
Biomerica director Catherine Coste acquired 85,000 shares of common stock through the vesting of restricted stock units.
NASDAQ
Biomerica's Chief Financial Officer, Gary Lu, acquired 155,000 shares of common stock through the vesting of restricted stock units.